ABC | Volume 114, Nº1, Janeiro 2020

Artigo Original Gomes et al. Caracterização de dislipidemias infanto-juvenis Arq Bras Cardiol. 2020; 114(1):47-56 1. WorldHealthOrganization (WHO). Cardiovascular diseases (CVDs). 2017; Available from: http://www.who.int/en/news-room/fact-sheets/detail/ cardiovascular-diseases-(cvds). 2. Sociedade Brasileira de Cardiologia . Cardiômetro: Mortes por doenças cardiovasculares no Brasil. 2015; Available from: http://www.cardiometro . com.br/. 3. Faludi AA, Izar MC, Saraiva JF, Chacra AP, Bianco HT, Afiune Neto A, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109(2 Suppl 1):1-76. 4. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from1990 to 2013. Circulation. 2015;132(17):1667-78. 5. Brasil.Leis, Decretos. Lei n. 8.069, de 13 de julho de 1990, e legislação correlata. Dispõe sobre o Estatuto da Criança e do Adolescente. DOU de 16/07/1990 – ECA; Brasilia,2012. 6. Napoli C, D’Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100(11):2680-90. 7. Zachariah JP, Johnson PK. Pediatric LipidManagement An Earlier Approach. Endocrinol Metab Clin North Am. 2014;43(4):981-92. 8. Faria-Neto J, Bento V, Baena C, Olandoski M, Goncalves L, Abreu G, et al. ERICA: prevalence of dyslipidemia in Brazilian adolescents. Rev Saude Publica. 2016;50(Suppl 1):10s. 9. Faria EC, Dalpino FB, Takata R. Lípides e lipoproteínas séricos em crianças e adolescentes ambulatoriais de umhospital universitário público. Rev Paul Pediatr. 2008;26(1):54-8. 10. Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20. 11. Kwiterovich PO. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008;93(11):4200-9. 12. Johansen IC, Carmo RL, Alves LC. Desigualdade social intraurbana: implicações sobre a epidemia de dengue em Campinas, SP, em 2014. Cad Metrop. 2016;18(36):421-40. 13. São Paulo. Estado. Secretaria de Saúde de Campinas. Estrutura - SUS Campinas. Campinas: Prefeitura Municipal de Campinas; 2017 [Citado 2018 abr 16] Disponível em: http://www.saude.campinas.sp.gov.br/saude/. 14. BerensonGS, Srinivasan SR, BaoW, NewmanWP, Tracy RE, WattigneyWA. Association betweenmultiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-6. 15. Dwyer T, Sun C, Magnussen CG, Raitakari OT, Schork NJ, Venn A, et al. Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium. Int J Epidemiol. 2013;42(1):86-96. 16. Magnussen CG, Raitakari OT, Thomson R, JuonalaM, Patel DA, Viikari JS, et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation. 2008;117(1):32-42. 17. Magnussen CG, Venn A, Thomson R, Juonala M, Srinivasan SR, Viikari JSA, et al. The Association of Pediatric Low- and High-Density Lipoprotein Cholesterol Dyslipidemia Classifications and Change inDyslipidemia Status With Carotid Intima-Media Thickness in Adulthood Evidence From the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study, and the CDAH (Childhood Determinants of Adult Health) Study. J AmColl Cardiol. 2009;53(10):860-9. 18. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, et al. Influence of Age on Associations Between Childhood Risk Factors and Carotid Intima-Media Thickness in Adulthood The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122(24):2514-20. 19. Quadros TM, Gordia AP, Silva RC, Silva LR. Predictive capacity of anthropometric indicators for dyslipidemia screening in children and adolescents. J Pediatr. 2015;91(5):455-63. 20. Tomeleri CM, Ronque ER, Silva DR, Cardoso Júnior CG, Fernandes RA, Teixeira DC, et al. Prevalence of dyslipidemia in adolescents: comparison between definitions. Rev Port Cardiol. 2015;34(2):103-9. 21. Pereira PB, Arruda IK, Cavalcanti AM, Diniz AA. Lipid profile of schoolchildren from Recife, PE. Arq Bras Cardiol. 2010;95(5):606-13. 22. Nguyen D, Kit B, Carroll M. Abnormal Cholesterol Among Children and Adolescents in the United States, 2011-2014. NCHS Data Brief. 2015 Dec;(228):1-8. 23. Barja Yáñez S, Arnaiz Gómez P, Villarroel Del Pino L, Domínguez de Landa A, Castillo Valenzuela O, Farías Jofré M, et al. Dyslipidemias in school-age chilean children: prevalence and associated factors. Nutr Hosp. 2015;31(5):2079-87. 24. Franca E, Alves JG. Dyslipidemia among adolescents and children from Pernambuco. Arq Bras Cardiol. 2006;87(6):722-7. 25. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272-9. 26. SociedadeBrasileiradeCardiologia. IDiretrizdePrevençãodaAterosclerose na Infância e na Adolescência. Arq Bras Cardiol. 2005;85(6):3-36. 27. Styne DM, Grumbach MM. Physiology and disorders of puberty. Williams Textbook of Endocrinology. 13 th ed. Philadelphia, PA: Elsevier; 2016. 28. Vashishta S, Gahlot S, Goyal R. Effect of Menstrual Cycle Phases on Plasma Lipid and Lipoprotein Levels in RegularlyMenstruatingWomen. J ClinDiagn Res. 2017;11(5):CC05-7 29. Zhang N, Zhang HQ, Zhang X, Zhang BC, Wang FR, Wang CG, et al. The relationship between endogenous testosterone and lipid profile in middle- aged and elderly Chinese men. Eur J Endocrinol. 2014;170(4):487-94. 30. Rabelo LM. Atherosclerotic risk factors in adolescence. J Pediatr. 2001;77(Suppl 2):S153-64. 31. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garcia FA, et al. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(6):625-33. 32. Ramos AT, Carvalho DF, Gonzaga NC, Cardoso AD, Noronha JA, Cardoso MA. Lipid profile in overweight children and adolescents. Journal of Human Growth and Development. 2011;21(3):780-8. 33. Hickman T, Briefel R, Carroll M, Rifkind B, Cleeman J, Maurer K, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the third National Health and Nutrition Examination Survey. Prev Med. 1998;27(6):879-90. 34. Bibiloni M, Salas R, NoveloH, Villarreal J, Sureda A, Tur J. SerumLipid Levels and Dyslipidaemia Prevalence among 2-10 Year-Old Northern Mexican Children. Plos One. 2015.2015;10(3): e0119877. Referências 55